european Industrial Pharmacy
The electronic journal of the EIPG
European Industrial Pharmacy is the electronic journal produced by the European Industrial Pharmacists Group (EIPG) and Euromed Communications between 2008 and 2017. The journal contains articles, news and comments of special interest to pharmaceutical scientists and executives working in the European pharmaceutical and allied industries. It is independently managed, has a European Editorial Advisory Board, and allows the voices of Industrial Pharmacists to be communicated to as wide an audience as possible.
Agreement with SFSTP and Éditions de Santé
SFSTP (Société Française des Sciences et Techniques Pharmaceutiques)
is a French association dedicated to the advancement of pharmaceutical sciences and techniques by bringing together the knowledge and energies of different players in the pharmaceutical industry and academia. The Society’s trademark publication, STP Pharma Pratiques
, is a bimonthly, bilingual (English and French) journal of industrial pharmacy published by Éditions de Santé
. The articles in the journal deal with the technical, industrial and regulatory aspects related to the development, production, control and quality assurance of health, cosmetics and veterinary products, and are sourced mainly from the working commissions of the SFSTP, which are composed of multidisciplinary actors (industrialists, suppliers, supervisory authorities and academics) from various backgrounds (pharmaceutical, biotechnology, cosmetics, veterinary and regulatory). As a result of the efforts of the French members of EIPG, the Conseil National de l’Ordre des Pharmaciens
, and in particular the EIPG Immediate Past President Jean-Pierre Paccioni, as well as the SFSTP President Danièle Bordi, and the Éditions de Santé Président Directeur Général Dominique Dupont, at the EIPG General Assembly held in Paris in 2016, an agreement was signed between EIPG, SFSTP and Éditions de Santé, whereby EIPG has been given access to publish articles of interest from back issues of STP Pharma Pratiques in european Industrial Pharmacy, thus enabling European industrial pharmacists to benefit from the work of SFSTP and the proceedings of its annual congress.
LATEST ISSUE • ISSUE 35 • DECEMBER 2017
European Industrial Pharmacy
Editorial Comment: The End of the Beginning
Regulatory consequences of data integrity failures
Data integrity inadequacies can easily lead to a statement of non-compliance, with serious regulatory consequences, and not only for the manufacturer concerned.
Revisions made to European Pharmacopoeia sterilisation chapters
Methods of sterilisation and the assessment of sterilisation using biological indicators represent important areas of regulatory concern.
Predicting production tablet properties from small scale manufacture
With growing use of the laboratory press system, the ability to predict production tablet properties from lab scale data becomes important. In this article, Michael Gamlen describes how this can be done.
Qualification of visual inspection of parenteral products
Commission SFSTP: F. Caire-Maurisier, F. Dumontier, P. Grel, C. Jolly, É. Levacher, S. Marcq, F. SliwinskiJim Polarine and Beth Kroeger
Visual inspection of parenteral products is required by both pharmacopoeias and good manufacturing practice. The SFSTP Commission have described the various methods and apparatuses commonly used in the pharmaceutical industry for visual inspection.
Pharma in Plenary
European Medicines Verification Organisation (EMVO) progress monitoring report
Read Issue 35